Skip to main content

Advertisement

Table 3 Causes of death

From: Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Cause of death ATG-PTCy cohort (n = 16) ATG cohort (n = 27)
Relapse 9 (56%) 8 (30%)
GVHD 0 7(26%)
Infection other than CMV/EBV 5 (31%) 10 (37%)
CMV disease 1 (6%) 0
Organ failure 1 (6%) 2 (7%)